Core Insights - Integer Holdings Corporation (NYSE: ITGR) is a leading medical device contract development and manufacturing organization, focusing on enhancing patient lives through innovative products and solutions [3]. Company Overview - Integer Holdings Corporation is one of the largest CDMO in the world, serving markets such as cardiac rhythm management, neuromodulation, and cardio and vascular [3]. - The company operates under well-known brands including Greatbatch Medical and Lake Region Medical [3]. Upcoming Events - The executive leadership team will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 8:00 a.m. ET [5]. - Additionally, they will attend Citi's 2025 Global Healthcare Conference on December 3, 2025, at 9:45 a.m. ET [5]. - Live webcasts and replays of these events will be available on the Investor Relations section of the Integer website [1].

Company Overview - Integer Holdings Corporation (NYSE: ITGR) is a leading medical device contract development and manufacturing organization (CDMO) serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets [3] - The company is recognized as a strategic partner for medical device companies and OEMs, focusing on enhancing patient lives through innovative, high-quality products and solutions [3] - Integer's brands include Greatbatch Medical and Lake Region Medical [3] Upcoming Events - Integer will participate in the 2025 Truist Securities MedTech Conference on June 17, 2025, in Boston, with a fireside chat scheduled for 10:40 a.m. ET [1] - A live webcast of the presentation will be available on the Investor Relations section of the Integer website [2]

Core Viewpoint - Integer Holdings Corporation is actively participating in the 2025 Bank of America Securities Health Care Conference, indicating its engagement with the healthcare investment community and commitment to showcasing its innovations in medical devices [1]. Company Overview - Integer Holdings Corporation (NYSE: ITGR) is a leading medical device contract development and manufacturing organization (CDMO) globally, focusing on cardiac rhythm management, neuromodulation, and cardio and vascular markets [3]. - The company serves as a strategic partner to medical device companies and OEMs, aiming to enhance patient lives through innovative and high-quality products [3]. - Integer's notable brands include Greatbatch Medical and Lake Region Medical, reflecting its strong market presence [3]. Event Details - The 2025 Bank of America Securities Health Care Conference will take place from May 13-15, 2025, in Las Vegas, where Integer's executive leadership will participate in a fireside chat on May 14 at 10:00 a.m. PT [1]. - A live webcast of the presentation will be available on the Investor Relations section of the Integer website, allowing broader access to stakeholders [2].

Core Insights - Integer Holdings Corporation reported a strong start to 2025 with a 7% year-over-year sales growth and a 14% increase in adjusted operating income [1][5] - The company raised its adjusted net income growth outlook to a range of 19% to 26% for 2025, while maintaining a sales growth forecast of 8% to 10% [1][4] Financial Performance - First quarter 2025 sales reached $437 million, up from $407.8 million in the same period last year, reflecting a 7% increase [5][18] - GAAP operating income increased by 28% to $50 million, while non-GAAP adjusted operating income rose by 14% to $71 million [5][37] - GAAP income from continuing operations showed a loss of $22 million, a decrease from a profit of $20.6 million in Q1 2024, primarily due to debt conversion inducement expenses [5][37] - Non-GAAP adjusted net income increased by 19% to $46 million, with adjusted EPS rising to $1.31 from $1.14 [5][41] Product Line Performance - Cardio & Vascular sales increased by 17% year-over-year, driven by new product launches and acquisitions [6] - Cardiac Rhythm Management & Neuromodulation sales grew by 2%, supported by emerging neuromodulation customers [6] - Other Markets sales decreased by 37%, primarily due to the planned exit from the Portable Medical market [6][18] 2025 Outlook - The company updated its 2025 outlook to reflect the impact of a $1 billion convertible note offering, which is expected to reduce interest expenses by $13 million [3][5] - Adjusted operating income for 2025 is projected to be between $331 million and $401 million, reflecting an 11% to 16% increase [4][5] - The leverage ratio as of March 28, 2025, was reported at 3.3 times adjusted EBITDA, with total debt increasing to $1.235 billion [5][12] Leadership Changes - The company announced that Joseph Dziedzic will retire as President and CEO on October 24, 2025, with Payman Khales set to assume the role [20]